scholarly journals Metastatic ameloblastoma responding to combination chemotherapy: case report and review of the literature

2011 ◽  
Vol 5 (1) ◽  
Author(s):  
Mounia Amzerin ◽  
Zouhour Fadoukhair ◽  
Rhizlane Belbaraka ◽  
Meryem Iraqui ◽  
Saber Boutayeb ◽  
...  
2006 ◽  
Vol 16 (Suppl 1) ◽  
pp. 391-393 ◽  
Author(s):  
G. Ostoros ◽  
A. Pretz ◽  
J. Fillinger ◽  
I. Soltesz ◽  
B. Dome

Fatal lung fibrosis caused by paclitaxel toxicity has not been reported In this report, we describe the case of a 62-year-old woman who received six cycles of paclitaxel and carboplatin as combination chemotherapy for advanced ovarian cancer. Four weeks after the end of the chemotherapy she developed interstitial pneumonitis and irreversible lung fibrosis. Despite treatment with corticosteroids, she had rapid deterioration and died of respiratory failure. Pulmonary fibrosis is a complication of paclitaxel therapy that may occur despite treatments with corticosteroids. While reviewing the literature, we found few less severe pulmonary injuries after intravenous use of paclitaxel, but none of these cases had a fatal outcome. Physicians should keep in mind that taxanes such as paclitaxel have the potential to cause pneumonitis and lung fibrosis.


2017 ◽  
Vol 5 (1) ◽  
pp. 35-39
Author(s):  
Vanda Salutari ◽  
Patricia Pautier

Ovarian small cell carcinoma is a rare tumor associated with poor prognosis. Although combination chemotherapy remains the cornerstone of treatment due to the rarity of these tumors, there is no evidencebased consensus for a standard treatment, although in the majority of cases platinum-based regimens are used. A case of small cell carcinoma of the ovary, hypercalcemic-type (SCCOHT), in a 22 year-old patient is reported.


1999 ◽  
Vol 19 (3) ◽  
pp. 328-335
Author(s):  
Shanop Shuangshoti Shuangshoti ◽  
Samruay Shuangshoti

Sign in / Sign up

Export Citation Format

Share Document